indiamed
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Magazine
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Magazine
facebook x icon x icon linkedin linkedin
cover-story

Post-Budget reaction: Dr Harshit Jain, Founder and Global CEO, Doceree

IMT News Desk
The Union Budget 2023-24 presented by our Finance Minister is committed to providing significant stimulus to the healthcare and pharmaceutical industry with increased allocation of funds (as compared to the previous year) and we duly welcome it. The government’s financial and infrastructural impetus focused on improving skilling and education in the sector, especially in nursing care and multidisciplinary knowledge in medical devices, shall significantly improve the availability of skilled personnel in healthcare. The introduction of a new programme to boost research and innovation in pharmaceuticals with the support of centres of excellence, coupled with encouragement for public-private collaboration for research purposes, is a welcoming move and has a huge potential to improve healthcare with revolutionary innovations and solutions. It shall also encourage the participation of health start-ups to provide on-ground support for the implementation of such forward-looking programmes. The introduction of new schemes under our Digital India goal to augment India’s proficiency in new-age technologies and solutions, shall also directly/indirectly benefit the healthcare and pharma industry in the years to come.

Recommended

India’s Orthopaedic and Cardiac Implant Market Set to Touch USD 5 Billion by FY28: CareEdge Ratings

Hinge Health Debuts on NYSE, Raises $437.3 Million

CureBay Secures $21 Million to Expand Rural Health Network

Pain Relief Revolution: Reinventing Chronic Care in India

Massive Turnover, Growing FDI: India’s Pharma Sector at a Crossroads

Biocon Eyes ₹4,500 Crore QIP to Clear Debt and Boost Biologics Stake

Precision Oncology Goes Local: 4baseCare’s Genomics Lab and Atlas Set to Transform Cancer Care

GlobalData Forecasts HIV Market to Exceed $32 Billion Across Seven Major Markets by 2033

Indiamedtoday

A premier media platform empowering healthcare professionals with critical business insights, news, and innovations to excel in a rapidly evolving industry.

EMAIL editorial@indiamedtoday.com

EMAIL sales@indiamedtoday.com

quick links

news health it interview opinion strategy magazine privacy policy terms and conditions

subscribe to our newsletter

Stay updated with the latest breakthroughs in Indian healthcare, medical research, and wellness insights.

    follow us

    facebook x icon x icon linkedin linkedin
    Copyright © 2025 INDIAMED TODAY Marketed By Screetract Solutions